Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
Journal
Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
15
07
2020
revised:
24
09
2020
accepted:
20
10
2020
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
9
3
2021
Statut:
epublish
Résumé
Liver transplantation (LT) is definitive treatment for end-stage liver disease. This study evaluated factors predicting successful evaluation in patients transferred for urgent inpatient LT evaluation. Eighty-two patients with cirrhosis were transferred for urgent LT evaluation from January 2016 to December 2018. Alcohol-associated liver disease was the common etiology of liver disease (42/82). Of these 82 patients, 35 (43%) were declined for LT, 27 (33%) were wait-listed for LT, 5 (6%) improved, and 15 (18%) died. Psychosocial factors were the most common reasons for being declined for LT (49%). Predictors for listing and receiving LT on multivariate analysis included Hispanic race (odds ratio [OR], 1.89;
Identifiants
pubmed: 33681683
doi: 10.1002/hep4.1644
pii: 02009842-202103000-00015
pmc: PMC7917272
doi:
Types de publication
Journal Article
Langues
eng
Pagination
516-525Subventions
Organisme : NCI NIH HHS
ID : K08 CA222676
Pays : United States
Informations de copyright
© 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of the American Association for the Study of Liver Diseases.
Références
Martin P, DiMartini A, Feng S, Brown R, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 2014;59:1144‐1165.
Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence‐based analysis of 15 years of experience. Liver Transpl 2011;17(Suppl. 2):S44‐S57.
Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, et al.; U.S. Acute Liver Failure Study Group . Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947‐954.
Maldonado JR, Dubois HC, David EE, Sher Y, Lolak S, Dyal J, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre‐transplant candidates. Psychosomatics 2012;53:123‐132.
Wu T, Sundaram V. Transplantation for acute‐on‐chronic liver failure. Clin Liver Dis (Hoboken) 2019;14:152‐155.
Chronic Liver Failure Consortium . Tools‐calculators: EASL‐CLIF Consortium Scores. https://www.clifresearch.com/ToolsCalculators.aspx . Published 2013. Accessed May 2020.
Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology 2017;152:1090‐1099.e1.
Guirguis J, Chhatwal J, Dasarathy J, Rivas J, McMichael D, Nagy LE, et al. Clinical impact of alcohol‐related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States. Alcohol Clin Exp Res 2015;39:2085‐2094.
Kling CE, Perkins JD, Carithers RL, Donovan DM, Sibulesky L. Recent trends in liver transplantation for alcoholic liver disease in the United States. World J Hepatol 2017;9:1315‐1321.
Cholankeril G, Ahmed A. Alcoholic liver disease replaces hepatitis C virus infection as the leading indication for liver transplantation in the United States. Clin Gastroenterol Hepatol 2018;16:1356‐1358.
Grant BF, Chou SP, Saha TD, Pickering RP, Kerridge BT, Ruan WJ, et al. Prevalence of 12‐month alcohol use, high‐risk drinking, and DSM‐IV alcohol use disorder in the United States, 2001‐2002 to 2012‐2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017;74:911‐923.
Da BL, Im GY, Schiano TD. COVID‐19 hangover: a rising tide of alcohol use disorder and alcohol‐associated liver disease. Hepatology 2020. https://doi.org/10.1002/hep.31307 .
doi: 10.1002/hep.31307
Bajaj JS, O’Leary JG, Tandon P, Wong F, Garcia‐Tsao G, Kamath PS, et al. Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures. Clin Gastroenterol Hepatol 2017;15:565‐574.e4.
Kim WR, Biggins SW, Kremers WK, Wisner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver‐transplant waiting list. N Eng J Med 2008;359:1018‐1026.
Ahn J, Sundaram V, Ayoub WS, Frenette C, Wong RJ. Hypoalbuminemia is associated with significantly higher liver transplant waitlist mortality and lower probability of receiving liver transplant. J Clin Gastroenterol 2018;52:913‐917.
Sundaram V, Jalan R, Wu T, Volk ML, Asrani SK, Klein AS, et al. Factors associated with survival of patients with severe acute‐on‐chronic liver failure before and after liver transplantation. Gastroenterology 2019;156:1381‐1391.e3.
Gutin L, Yao F, Dodge JL, Grab J, Mehta N. Comparison of liver transplant wait‐list outcomes among patients with hepatocellular carcinoma with public vs private medical insurance. JAMA Netw Open 2019;2:e1910326.